Teva Pharmaceutical Industries Pre-Tax Income 2010-2025 | TEVA
Teva Pharmaceutical Industries pre-tax income for the twelve months ending March 31, 2025 was $-0.523B, a 36.14% decline year-over-year.
- Teva Pharmaceutical Industries annual pre-tax income for 2024 was $-1.284B, a 105.77% increase from 2023.
- Teva Pharmaceutical Industries annual pre-tax income for 2023 was $-0.624B, a 80.27% decline from 2022.
- Teva Pharmaceutical Industries annual pre-tax income for 2022 was $-3.163B, a 580.7% decline from 2021.